Johnson & Johnson raised its 2025 revenue outlook and beat Q3 estimates, while announcing plans to spin off its orthopedics unit DePuy Synthes as an independent company.
#YonhapInfomax #JohnsonAndJohnson #RevenueOutlook #DePuySynthes #Q3Earnings #SpinOff #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=85471
#YonhapInfomax #JohnsonAndJohnson #RevenueOutlook #DePuySynthes #Q3Earnings #SpinOff #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=85471